This blog is designed for Fred Hutchinson Cancer Center referring providers who bring world-class cancer care to their patients. Gain timely insights from our nationally-renowned experts through our e-newsletter. We are privileged to partner with you.
Taking a frothy risk to advance gene therapy
Fred Hutch scientists hope foam could be a cost-reducing, access-enhancing vehicle for delivering future gene therapies
Comprehensive Hematology and Oncology Review Course marks 15 years
Started as a personal project, oncology course now covers hematology, too
Breast cancer screening guidelines change — again
U.S. Preventive Services Task Force recommends mammograms every other year for those at average risk, starting at age 40
Bacteria subtype linked to growth in up to 50% of human colorectal cancers, Fred Hutch researchers report
A study published in Nature suggests that a subtype of Fusobacterium nucleatum underlies colorectal cancer growth in humans and could be useful in screening and treatments
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer
The New England Journal of Medicine published findings of a blood test for detecting circulating tumor DNA in people with average risk of colorectal cancer
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
Immune cells vs. metastasis: ‘It’s a numbers game’
Fred Hutch scientists prevent metastasis by boosting cancer-killing T cells in patients
Reducing frequency of immunotherapy dosing could save money and time, keep patients on therapy longer
Study of immune checkpoint inhibitor dosing in patients with advanced skin cancers could help guide long-term treatment plans
How do we increase equity in cancer care?
HICOR’s Value in Cancer Care Summit brings together stakeholders to discuss barriers, pain points and solutions